К содержанию
Dr. Tara EinullaevaMedical oncologist

Diagnosis and tests 6 min

Breast cancer in men: how treatment differs and why a BRCA test matters

Breast cancer in men: symptoms, risk factors, the role of BRCA2 mutations, hormone receptors, surgery, tamoxifen and the specifics of hormone therapy in men, treatment of metastatic disease.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 31 October 2026

Breast cancer in men is a rare disease, and that is exactly why it is often diagnosed late. A man may not see a lump in the chest as a reason for serious investigation, and a doctor sometimes does not think of this cause. Yet with timely treatment the results are similar to those in women.

In this article I describe the symptoms, risk factors, the role of genetics, how diagnosis and treatment go, how hormone therapy differs in men and how to be followed afterwards.

Symptoms that should not be ignored

  • a firm painless lump under or beside the nipple;
  • nipple retraction, skin changes (redness, crusting, ulceration);
  • discharge from the nipple, especially bloody;
  • enlarged lymph nodes in the armpit.

Gynaecomastia (enlargement of the breast in men, more often on both sides and tender) is far more common and is usually not cancer, but any one-sided firm lump must be investigated.

Risk factors

Factor Comment
BRCA2 mutations, less often BRCA1 The most significant hereditary factor
Klinefelter syndrome Raises the risk
Obesity, liver disease Lead to higher oestrogen levels
Previous chest radiotherapy Raises the risk
Family history of breast, ovarian or prostate cancer A reason to see a geneticist
Age More common in older age

More on hereditary mutations: BRCA test, BRCA.

How the diagnosis is made

  1. Examination and palpation of lymph nodes.
  2. Mammography and ultrasound of the breast and armpit nodes.
  3. Core needle biopsy of the lump.
  4. Pathology with immunohistochemistry: oestrogen and progesterone receptors, HER2, Ki-67 (ER/PR receptors, HER2, Ki-67, IHC in breast cancer).
  5. Staging if spread is suspected: CT, bone scan or PET-CT (what PET-CT shows).
  6. Genetic testing: recommended for all men with breast cancer regardless of family history.

In most men the tumour is hormone-positive (ER+), and HER2-positive cases are rare. This matters: hormone therapy becomes the main treatment.

Surgery

Most often mastectomy (removal of the breast) is done, because men have little glandular tissue and preserving the breast is difficult. In selected cases breast-conserving surgery is possible. The armpit nodes are usually assessed first by sentinel node biopsy, and if involved a wider operation is done.

Radiotherapy after surgery is given for the same indications as in women: large tumour, involved nodes, positive margins.

Drug treatment

Hormone therapy. If the tumour is ER-positive it is necessary. The main drug is tamoxifen, usually for 5 years and longer when indicated (tamoxifen, hormone therapy in breast cancer).

What distinguishes men:

  • aromatase inhibitors (aromatase inhibitors) work less well in men if taken alone, because suppressing oestrogen is accompanied by higher testicular activity. They are used only together with drugs that suppress testicular function (GnRH analogues) or if tamoxifen cannot be taken;
  • side effects in men have their own features: hot flushes, weight gain, reduced libido, erectile dysfunction, mood, thrombosis.

Because of side effects some men stop tamoxifen early. It is worth discussing this with the doctor rather than deciding alone: there are drug replacements, symptom management and other options. In detail: side effects and adherence to treatment.

Chemotherapy. Indications are determined by the same principles as in women: tumour size, node involvement, Ki-67, subtype. If the tumour is HER2-positive, anti-HER2 therapy is added: HER2-positive breast cancer. On regimens: chemotherapy regimens.

Metastatic breast cancer in men

In advanced hormone-positive disease the following are used:

  • hormone therapy (tamoxifen, fulvestrant, aromatase inhibitors with suppression of the testes);
  • CDK4/6 inhibitors together with hormone therapy (CDK4/6 inhibitors);
  • chemotherapy if the disease is fast or hormone therapy has stopped working;
  • anti-HER2 therapy in HER2-positive disease;
  • drugs that act in BRCA mutation (PARP inhibitors) if it is present.

Most data on effectiveness come from women, but in clinical practice the regimens are also used in men. This is one of the cases where the centre's experience matters.

What matters to know about genetics and family

If a BRCA2 (or BRCA1) mutation is found in you:

  • relatives, including daughters and sisters, are advised to discuss testing and screening for breast and ovarian cancer;
  • male carriers have a higher risk of prostate cancer, so earlier surveillance and PSA testing are discussed (PSA test);
  • the result may influence the choice of drugs.

Follow-up

After treatment, follow-up includes examinations and regular assessment of the remaining breast and nodes. Osteoporosis with long-term hormone therapy and lower testosterone is worth monitoring (bone density scan) if there is risk.

The emotional side

Many men feel confusion and embarrassment because the disease is seen as "female". This is normal, and talking to a doctor, psychologist or support group helps. Relatives may find it useful to read: how to support a loved one.

What to ask your doctor

  • What is the tumour subtype, receptors and HER2? Ki-67?
  • Was a genetic test done? Do relatives need to be told?
  • Is chemotherapy needed or is hormone therapy enough?
  • How long should I take tamoxifen and how do I cope with side effects?
  • Is radiotherapy needed?
  • Do I need follow-up with a urologist because of prostate cancer risk?
  • How will we follow up after treatment?

When to seek urgent help

  • temperature of 38 °C or above on chemotherapy;
  • swelling and pain in one leg, shortness of breath, chest pain (possible thrombosis on tamoxifen, see thrombosis in cancer);
  • bleeding or increasing pain at the operation site;
  • severe bone pain or sudden weakness in the legs.

Can I get a second opinion

Yes, and in male breast cancer it is especially useful because of the small number of cases and the limited experience of many doctors. Reasons: receptors or HER2 were not determined, no genetic test was offered, hormone therapy was not discussed, the question of chemotherapy needs deciding or the disease has returned. Prepare the pathology, IHC, scans and summaries: documents for a second opinion, preparing for a consultation. If you need a review, book a consultation: I study the documents in advance and send a written summary. General information: breast cancer.

Sources

  1. Male Breast Cancer Treatment (PDQ) — National Cancer Institute
  2. ESMO Clinical Practice Guidelines — ESMO
  3. Practical guidelines for drug treatment of malignant tumours — RUSSCO (Russian Society of Clinical Oncology)
  4. Clinical guidelines (Russia) — Russian Ministry of Health

Frequently asked questions

This article is for information only and does not replace a consultation with your treating doctor. Decisions about tests and treatment are made by the doctor who looks after you.